A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial
- Climent, M.A.
- Font, A.
- Durán, I.
- Puente, J.
- José Méndez-Vidal, M.
- Sáez, M.I.
- Santander Lobera, C.
- Ángel Arranz Arija, J.
- González-del-Alba, A.
- Sánchez-Hernandez, A.
- Juan Fita, M.J.
- Esteban, E.
- Alonso-Gordoa, T.
- Mellado Gonzalez, B.
- Maroto, P.
- Lázaro-Quintela, M.
- Cassinello-Espinosa, J.
- Pérez-Valderrama, B.
- Garcias, C.
- Castellano, D.
ISSN: 1879-0852, 0959-8049
Year of publication: 2022
Volume: 175
Pages: 110-119
Type: Article